Live Breaking News & Updates on ஜநெஸிஸ் மருந்து கண்டுபிடிப்பு வளர்ச்சி

Stay updated with breaking news from ஜநெஸிஸ் மருந்து கண்டுபிடிப்பு வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genesis Drug Discovery and Development Acquires Integrated Analytical Solutions to Add "Off the Shelf" PK Profiling Capabilities to Its Portfolio


Genesis Drug Discovery and Development Acquires Integrated Analytical Solutions to Add Off the Shelf PK Profiling Capabilities to Its Portfolio
News provided by
Share this article
® (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development™ (GD
3) announced today that it has acquired the Berkeley-based CRO Integrated Analytical Solutions (IAS). Founded in 2004 and located in the San Francisco bay area, IAS is a GxP-compliant CRO providing bioanalytical, drug metabolism, and analytical chemistry services to clients worldwide.
Integrated Analytical Solutions (IAS) Logo
This is our second acquisition in the space of two months as we further expand our presence in the San Francisco bay area, which we see as a market with tremendous growth potential for drug discovery services said Eli Mordechai, Ph.D., Chief Executive Officer (CEO) of GBG. Adding IAS s GxP compliant bioanalytical platform to GD ....

San Francisco Bay , United States , Prabal Banerjee , Eli Mordechai , Jonah Michaelian , Ben Bandaru , Contract Research Organization , Analytical Solutions Inc , Corporate Development , Genesis Drug Discovery Development , Analytical Solutions , Genesis Biotechnology Group , Business Development , Genesis Biotechnology , Genesis Drug Discovery , San Francisco , Chief Executive Officer , Biotechnology Group , Drug Discovery , Comparative Biosciences , New England Discovery Partners , Quality Management System , Genesis Drug Discovery Amp Development Gd3 , சான் பிரான்சிஸ்கோ வளைகுடா , ஒன்றுபட்டது மாநிலங்களில் , பிரபல் பானர்ஜி ,

Genesis Drug Discovery and Development Expands Its Presence in the Clinical Space by Acquiring STATKING Clinical Services


Genesis Drug Discovery and Development Expands Its Presence in the Clinical Space by Acquiring STATKING Clinical Services
News provided by
Share this article
® (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development™ (GD
3) announced today that it has acquired the Cincinnati-based CRO STATKING Clinical Services. Established in 1989, STATKING provides clinical trial services, including clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management for the regulatory approval of novel drug and medical device products.
STATKING Clinical Services
We are very pleased to have STATKING join GBG, and this acquisition demonstrates our commitment to making GD ....

United States , Prabal Banerjee , Eli Mordechai , Ben Bandaru , Contract Research Organization , Corporate Development , Clinical Services , Genesis Drug Discovery Development , Genesis Biotechnology Group , Business Development , Genesis Biotechnology , Genesis Drug Discovery , Chief Executive Officer , Biotechnology Group , Medicinal Chemistry , Comparative Biosciences , New England Discovery Partners , ஒன்றுபட்டது மாநிலங்களில் , பிரபல் பானர்ஜி , எலி மோர்டெச்சை , பென் பண்டாரு , ஒப்பந்த ஆராய்ச்சி ஆர்கநைஸேஶந் , பெருநிறுவன வளர்ச்சி , மருத்துவ சேவைகள் , ஜநெஸிஸ் மருந்து கண்டுபிடிப்பு வளர்ச்சி , ஜநெஸிஸ் உயிரி தொழில்நுட்பவியல் குழு ,